✦ LIBER ✦

Power and Sample Size Determination in Clinical Trials with Multiple Primary Continuous Correlated Endpoints

✍ Scribed by Lafaye de Micheaux, Pierre; Liquet, Benoit; Marque, Sébastien; Riou, Jérémie

Book ID: 126552837
Publisher: Taylor and Francis Group
Year: 2014
Tongue: English
Weight: 379 KB
Volume: 24
Category: Article
ISSN: 1054-3406
DOI: 10.1080/10543406.2013.860156

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sample size determination in clinical tr

Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables

✍ Takashi Sozu; Tomoyuki Sugimoto; Toshimitsu Hamasaki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

Determination of Power and Sample Size i

Determination of Power and Sample Size in the Design of Clinical Trials with Failure-Time Endpoints and Interim Analyses

✍ Minggao Gu; Tze Leung Lai 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Bayesian Sample Size Determination for a

Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes

✍ Stamey, James D.; Natanegara, Fanni; Seaman, John W. 📂 Article 📅 2013 🏛 Taylor and Francis Group 🌐 English ⚖ 504 KB

Sample size determination for the two-st

Sample size determination for the two-stage design of a phase II cancer clinical trials with correlated unbalance binary endpoints

✍ Yu Shyr; Brenda P. Nicholson; David H. Johnson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 76 KB

[Wiley Series in Probability and Statist

[Wiley Series in Probability and Statistics] Sample Size Determination and Power (Ryan/Sample) || Clinical Trials

✍ Ryan, Thomas P. 📂 Article 📅 2013 🏛 Wiley ⚖ 171 KB

Sample size determination in complex cli

Sample size determination in complex clinical trials comparing more than two groups for survival endpoints

✍ Sang Ahnn; Stewart J. Anderson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

This paper presents a sample size formula for testing the equality of k (\*2) survival distributions using the Tarone-Ware class of test statistics in the presence of non-proportional hazards, time dependent losses, non-compliance and drop-in. This method extends the derivation by Lakatos of a sampl